Search Tag: Sepsis
2024 21 Apr
Sepsis is a Medical Emergency Requiring Immediate Diagnosis & Treatment Pancreatic Stone Protein (PSP) on the abioSCOPE® is the Earliest Marker of Sepsis Sepsis is a major healthcare burden claiming more than 11 million lives per year, one death every 2.8 seconds 1 . It is caused by a dysregulated host response to infection which...Read more
2024 12 Mar
An overview of landiolol, a potent and cardioselective beta-blocker offering a promising addition to the armamentarium for managing acute cardiac conditions for rapid and effective rate control with minimal adverse effects. Cardiac emergencies present complex challenges in emergency medical settings, requiring prompt and effective management...Read more
2024 20 Mar
Session One March 20, 2024 | 3:00 PM EST Session Two March 28, 2024 | 1:00 PM EST Session Three March 26, 2024 | 11:00 AM GMT Read more
2023 30 Nov
Intensive care impacts more than the patient, with ripple effects for families, employers and wider societies. Patient-centred outcomes reiterate the need for clinical therapies targeting the biological circuitry of the big-hitting syndromes like ARDS, sepsis, delirium, renal failure and recognising they persist beyond the veil of discharge....Read more
2023 30 Nov
An overview of vasopressor management, current evidence on its use, when to initiate vasopressor therapy for best possible patient outcome and a discussion regarding the use of landiolol in septic patients with persistent tachycardia. Optimising Vasopressin Initiation in Septic Shock Patients with septic shock, and especially...Read more
2023 13 Oct
Vasopressin and landiolol are critical therapies for ensuring the vascular and cardiac systems are as close to optimal conditions as possible during septic shock. Better cardiovascular management in septic shock can help improve septic shock management. Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response...Read more
2023 13 Oct
The use of Artificial Intelligence in detecting sepsis, AI prediction/detection models and how these healthcare tools need to complement clinical expertise. The potential of Artificial Intelligence (AI) in healthcare has generated significant excitement and discussion. However, it's important to distinguish between the theoretical...Read more
2023 12 Sep
A woman came to see me a few days ago: her 44-year-old husband recently died from sepsis in another hospital, and she wanted to have a discussion about this tragic story. Her husband had had just some kind of blister on his foot. He didn’t seem very ill when he arrived at the hospital, but he quickly developed an extended area of fasciitis on his left...Read more
2023 12 Sep
Corticosteroid use in the care of critically ill patients has been the subject of ongoing research with conflicting findings. There is a growing interest in understanding their role in treating a common source of sepsis: community-acquired pneumonia (CAP). Some studies have focused on determining whether corticosteroids provide clinical benefits to...Read more
2023 08 Sep
World Sepsis Day falls on September 13. Sepsis, which kills more people in Austria each year than heart attacks, is caused by an infection which spreads through the body and damages our organs. A lot of people in the general public still do not know very much about this issue. Sepsis is one of the most common causes of death around the world....Read more
2023 01 Aug
Computer-based technologies, including artificial intelligence (AI) applications like ChatGPT and DALL-E, are being increasingly used and can mimic human capabilities, even passing medical board examinations. Retrospective studies have shown that machine learning (ML) applications are especially valuable in the ICU due to their diagnostic and prognostic...Read more
2023 06 Dec
<marquee behavior="slide" direction="left" scrollamount="30"><h2 style="text-align: center;"><font color="#000099"><b>Find ESEM on Social Media</b> </font></h2><div style="text-align: center;"><a href=https://www.twitter.com/UAE_ESEM target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=85 height=85></a&Read more
2023 13 Mar
This article describes the application of existing and emerging biomarkers in the diagnosis and management of sepsis and pneumonia. Introduction: The Need for Biomarkers in Sepsis Sepsis is defined as a dysregulated host response to infection that results in life threatening organ dysfunction. It carries an estimated...Read more
2023 13 Mar
A biomarker defines a measurable indicator of a patient's medical situation that can be measured precisely and accurately. Biomarkers provide value for diagnosis, prognosis, early disease detection, risk stratification, suitable treatment (theragnostic), and trial improvement for patients with sepsis or presumed sepsis. Introduction...Read more
2023 13 Mar
An overview of tachycardia in sepsis, the importance of rate control and the beneficial effects of beta-blockers. Sepsis and Tachycardia – Aetiologic Factors During sepsis, the sympathetic nervous system plays a key role in maintaining cardiac output and blood pressure. This is achieved through changes...Read more
2022 08 Dec
Imaging is integral to managing critically ill patients in the ICU as it is a key source of diagnostic information to guide clinical decision-making. In recent years, there has been significant evolution in the field of critical care imaging with an increased focus on improving imaging modalities and methodologies and increasing access to imaging...Read more
2022 08 Dec
An overview of clinical evidence that demonstrates the prognostic value of estimated plasma volume (ePVS) in critically ill patients. Relevance Plasma volume (PV) is the total volume of blood plasma – the extracellular fluid volume of the vascular space. It is associated with regulating interstitial and intravascular spaces; hence it can...Read more
2022 08 Dec
The role of point-of-care testing in the early identification and management of sepsis, the need for better markers to identify sepsis, an overview of the Pancreatic Stone Protein (PSP) and clinical evidence highlighting its effectiveness as a biomarker. Pancreatic Stone Protein Infections are a leading cause of morbidity and mortality...Read more
2022 31 May
Sepsis is one of the most challenging complications in the ICU. It is a physiologic response to infection that could lead to multiorgan failure and death if not managed and treated properly. Sepsis is a major health issue in the U.S., with more than 1.7 million cases diagnosed annually. Sepsis is also a leading cause of death and one of the most expensive...Read more
2022 25 May
An overview of a discussion on sepsis and the Pancreatic Stone Protein (PSP) biomarker by Dr João Pereira, Hospital De Vila Franca De Xira, Portugal and how it can be used for early diagnosis of sepsis and facilitate decision-making regarding the administration of antibiotics. The discussion was chaired by Prof Pedro Póvoa, coordinator of...Read more
2022 27 Apr
The risk of late mortality in sepsis survivors can persist for years with high readmission rates and poor quality of life. However, due to an incomplete understanding of the relevant causal mechanisms of post-sepsis syndrome, there has been limited success in implementing preventive interventions. The French and European Outcome Registry in Intensive...Read more